Sweden · Delayed Price · Currency is SEK MedCap AB Statistics
Total Valuation
MedCap AB has a market cap or net worth of SEK 8.33 billion. The enterprise value is 8.51 billion.
| Market Cap | 8.33B |
| Enterprise Value | 8.51B |
Important Dates
The last earnings date was Tuesday, July 21, 2026.
| Earnings Date | Jul 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MedCap AB has 14.98 million shares outstanding. The number of shares has increased by 0.47% in one year.
| Current Share Class | 14.98M |
| Shares Outstanding | 14.98M |
| Shares Change (YoY) | +0.47% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 1.17% |
| Owned by Institutions (%) | 38.75% |
| Float | 11.83M |
Valuation Ratios
The trailing PE ratio is 34.64 and the forward PE ratio is 25.17.
| PE Ratio | 34.64 |
| Forward PE | 25.17 |
| PS Ratio | 3.69 |
| PB Ratio | 5.25 |
| P/TBV Ratio | 38.94 |
| P/FCF Ratio | 22.93 |
| P/OCF Ratio | 21.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.30, with an EV/FCF ratio of 23.41.
| EV / Earnings | 35.36 |
| EV / Sales | 3.77 |
| EV / EBITDA | 16.30 |
| EV / EBIT | 24.62 |
| EV / FCF | 23.41 |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.86 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 0.88 |
| Debt / FCF | 1.26 |
| Interest Coverage | 7.08 |
Financial Efficiency
Return on equity (ROE) is 16.36% and return on invested capital (ROIC) is 14.48%.
| Return on Equity (ROE) | 16.36% |
| Return on Assets (ROA) | 8.15% |
| Return on Invested Capital (ROIC) | 14.48% |
| Return on Capital Employed (ROCE) | 15.50% |
| Weighted Average Cost of Capital (WACC) | 7.02% |
| Revenue Per Employee | 3.49M |
| Profits Per Employee | 371,870 |
| Employee Count | 637 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 3.06 |
Taxes
In the past 12 months, MedCap AB has paid 72.50 million in taxes.
| Income Tax | 72.50M |
| Effective Tax Rate | 23.10% |
Stock Price Statistics
The stock price has decreased by -9.66% in the last 52 weeks. The beta is 0.49, so MedCap AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -9.66% |
| 50-Day Moving Average | 520.41 |
| 200-Day Moving Average | 520.00 |
| Relative Strength Index (RSI) | 59.68 |
| Average Volume (20 Days) | 12,923 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedCap AB had revenue of SEK 2.26 billion and earned 240.60 million in profits. Earnings per share was 16.07.
| Revenue | 2.26B |
| Gross Profit | 1.34B |
| Operating Income | 317.20M |
| Pretax Income | 313.80M |
| Net Income | 240.60M |
| EBITDA | 522.00M |
| EBIT | 345.50M |
| Earnings Per Share (EPS) | 16.07 |
Balance Sheet
The company has 286.30 million in cash and 457.60 million in debt, with a net cash position of -171.30 million or -11.44 per share.
| Cash & Cash Equivalents | 286.30M |
| Total Debt | 457.60M |
| Net Cash | -171.30M |
| Net Cash Per Share | -11.44 |
| Equity (Book Value) | 1.59B |
| Book Value Per Share | 105.91 |
| Working Capital | 472.40M |
Cash Flow
In the last 12 months, operating cash flow was 387.30 million and capital expenditures -23.90 million, giving a free cash flow of 363.40 million.
| Operating Cash Flow | 387.30M |
| Capital Expenditures | -23.90M |
| Depreciation & Amortization | 111.70M |
| Net Borrowing | 55.30M |
| Free Cash Flow | 363.40M |
| FCF Per Share | 24.27 |
Margins
Gross margin is 59.38%, with operating and profit margins of 14.05% and 10.66%.
| Gross Margin | 59.38% |
| Operating Margin | 14.05% |
| Pretax Margin | 13.90% |
| Profit Margin | 10.66% |
| EBITDA Margin | 22.51% |
| EBIT Margin | 14.90% |
| FCF Margin | 16.10% |
Dividends & Yields
MedCap AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.47% |
| Shareholder Yield | -0.47% |
| Earnings Yield | 2.89% |
| FCF Yield | 4.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 27, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |